News & Updates

Semaglutide for weight management beneficial to Asians with overweight, obesity

Treatment with semaglutide induces weight loss in Asians with overweight or obesity, regardless of the presence of type 2 diabetes, according to the phase IIIa STEP 7 study.

AI model improves thyroid cancer diagnosis

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.

Reduced social isolation, loneliness helps people with obesity live longer

Addressing social isolation and loneliness in people with obesity can counter their increased risk of death, according to a study.

High saturated fat intake tied to poor low- and high-contrast visual acuity

Increased saturated fat intake in young adults appear to exert detrimental effects on high-contrast (HC) and low-contrast (LC) visual acuity (VA), according to a study.

Sleeve gastrectomy, gastric bypass deliver low perioperative risk

Two weight-loss surgical procedures, namely laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass, are both safe, with similarly low risk of complications during and immediately after the procedure, according to a study.

Evinacumab hits mark in difficult-to-treat children with rare lipid disorder

The angiopoietin-like 3 inhibitor evinacumab appears to reduce low-density lipoprotein cholesterol (LDL-C) levels in children with homozygous familial hypercholesterolemia (HoFH) and persistently high LDL-C despite optimized therapy.

Robust evidence for fenofibrate in patients with metabolic syndrome on statins